Epithalon exhibited anti-cancer effects in both animal and human test subjects. A 2007 study by Vinogradova, the peptide was found to significantly inhibited the development of tumors in female rats exposed to a standardized about of natural light.
Epithalon is used to treat hormone-dependent tumors in Russia as well as menopause-related symptoms and anovulatory infertility.
Our quest is to differentiate ourselves from our competitors, by providing a distinct health care experience.